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Reply to letter entitled “The mechanisms of
ultra-low dose opioid agonist-antagonist”We thank Wong and his colleagues for their interest in our
articles.1,2 We agree with their comment that reduction of
overall postoperative nausea and vomiting may occur as
a result of nalbuphine’s binding affinity to mu-opioid
receptors while analgesic effect could be restored by its
kappa-opioid agonistic property. Furthermore, they pointed
out crucial role of morphine sparing effect to serve as the
main mechanism of combining adjuvant with morphine in
reducing morphine-related side effects. Our results were
consistent with Cepeda et al.3 that the 24 h morphine
requirement and pain intensity levels were similar in both
group. However, Cepeda et al. had performed an analysis of
repeated measures using generalized estimating equations
to calculate differences in pain intensity and pain relief.
They found that morphine plus naloxone required 0.07 mg
more morphine during than the morphine group while the
combination group had 0.06 units less pain intensity levels
than morphine group. Although it is statistically significant,
it may not be clinically significant. In another study, we
demonstrate that combining dexmedetomidine and
morphine for intravenous patient-controlled analgesia have
morphine sparing effect and less side effects.4 As a result,
we agree with Wong et al. that morphine sparing effect is
one of the mechanisms to reduce morphine-related side
effect. Gauging the balance and efficacy of analgesic
medication, we highly recommend the multimodal proto-
cols in combination to achieve the goal.
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